Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment

Alcohol

Volumn 42, Issue 7, 2008, Pages 553-563

  Williams, Keith L ^a   Schimmel, Jasmine S ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Antagonists; Ethanol; Naltrexone; Reinstatement; Self administration

Indexed keywords

ALCOHOL; NALTREXONE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; AUDITORY STIMULATION; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MODEL; EXPOSURE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; RAT; REINFORCEMENT; RELAPSE; TASK PERFORMANCE; VISUAL STIMULATION; WITHDRAWAL SYNDROME;

ALCOHOL DRINKING; ANIMALS; CONDITIONING (PSYCHOLOGY); CUES; ETHANOL; EXTINCTION, PSYCHOLOGICAL; MALE; NALTREXONE; RATS; RATS, LONG-EVANS;

RATTUS;

EID: 53049104678     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2008.06.003     Document Type: Article

References (57)

1. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295 (2006) 2003-2017
2. Backstrom P., and Hyytia P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol. Clin. Exp. Res. 28 (2004) 558-565
3. Backstrom P., and Hyytia P. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur. J. Pharmacol. 528 (2005) 110-118
4. Bienkowski P., Kostowski W., and Koros E. Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur. J. Pharmacol. 374 (1999) 321-327
5. Bienkowski P., Kostowski W., and Koros E. The role of drug-paired stimuli in extinction and reinstatement of ethanol-seeking behaviour in the rat. Eur. J. Pharmacol. 374 (1999) 315-319
6. Blakey R., and Baker R. An exposure approach to alcohol abuse. Behav. Res. Ther. 18 (1980) 319-325
7. Burattini C., Gill T.M., Aicardi G., and Janak P.H. The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience 139 (2006) 877-887
8. Ciccocioppo R., Angeletti S., and Weiss F. Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. Alcohol. Clin. Exp. Res. 25 (2001) 1414-1419
9. Ciccocioppo R., Lin D., Martin-Fardon R., and Weiss F. Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology (Berl) 168 (2003) 208-215
10. Ciccocioppo R., Martin-Fardon R., and Weiss F. Effect of selective blockade of m1 or d opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27 (2002) 391-399
11. Czachowski C.L., Samson H.H., and Denning C.E. Blood ethanol concentrations in rats drinking sucrose/ethanol solutions. [see comments]. Alcohol. Clin. Exp. Res. 23 (1999) 1331-1335
12. Drummond D.C., and Glautier S. A controlled trial of cue exposure treatment in alcohol dependence. J. Consult. Clin. Psychol. 62 (1994) 809-817
13. Gastpar M., Bonnet U., Boning J., Mann K., Schmidt L.G., Soyka M., et al. Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J. Clin. Psychopharmacol. 22 (2002) 592-598
14. Heather N., and Greeley J. Cue exposure in the treatment of drug dependence: the potential of a new method for preventing relapse. Drug Alcohol. Rev. 9 (1990) 155-168
15. Heinala P., Alho H., Kiinmaa K., Lonnqvist J., Kuoppasamlmi K., and Sinclair J.D. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 21 (2001) 287-292
16. Hernandez-Avila C.A., Song C., Kuo L., Tennen H., Armeli S., and Kranzler H.R. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Alcohol. Clin. Exp. Res. 30 (2006) 860-865
17. Heyman G.M. Preference for saccharin-sweetened alcohol relative to isocaloric sucrose. Psychopharmacology (Berl) 129 (1997) 72-78
18. Heyman G.M. An economic approach to animal models of alcoholism. Alcohol. Res. Health 24 (2000) 132-139
19. Heyman G.M., Gendel K., and Goodman J. Inelastic demand for alcohol in rats. Psychopharmacology (Berl) 144 (1999) 213-219
20. Juarez J., and Eliana Bde T. Alcohol consumption is enhanced after naltrexone treatment. Alcohol. Clin. Exp. Res. 31 (2007) 260-264
21. Karhuvaara S., Simojoki K., Virta A., Rosberg M., Loyttyniemi E., Nurminen T., et al. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Alcohol. Clin. Exp. Res. 31 (2007) 1179-1187
22. Katner S.N., Magalong J.G., and Weiss F. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20 (1999) 471-479
23. Katner S.N., and Weiss F. Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol. Clin. Exp. Res. 23 (1999) 1751-1760
24. Krank M.D., and Wall A.M. Cue exposure during a period of abstinence reduces the resumption of operant behavior for oral ethanol reinforcement. Behav. Neurosci. 104 (1990) 725-733
25. Kranzler H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol. Alcohol. 35 (2000) 537-547
26. Kranzler H.R., Armeli S., Tennen H., Blomqvist O., Oncken C., Petry N., et al. Targeted naltrexone for early problem drinkers. J. Clin. Psychopharmacol. 23 (2003) 294-304
27. Kranzler H.R., and Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol. Clin. Exp. Res. 25 (2001) 1335-1341
28. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., and Rosenheck R.A. Naltrexone in the treatment of alcohol dependence. N. Engl. J. Med. 345 (2001) 1734-1739
29. Liu X., and Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 22 (2002) 7856-7861
30. Lukas G., Brindle S.D., and Greengard P. The route of absorption of intraperitoneally administered compounds. J. Pharmacol. Exp. Ther. 178 (1971) 562-564
31. Monti P.M., Binkoff J.A., Abrams D.B., Zwick W.R., Nirenberg T.D., and Liepman M.R. Reactivity of alcoholics and nonalcoholics to drinking cues. J. Abnorm. Psychol. 96 (1987) 122-126
32. Monti P.M., Rohsenow D.J., Hutchison K.E., Swift R.M., Mueller T.I., Colby S.M., et al. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol. Clin. Exp. Res. 23 (1999) 1386-1394
33. Monti P.M., Rohsenow D.J., Swift R.M., Gulliver S.B., Colby S.M., Mueller T.I., et al. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol. Clin. Exp. Res. 25 (2001) 1634-1647
34. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
35. Niaura R.S., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., and Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. J. Abnorm. Psychol. 97 (1988) 133-152
36. O'Malley S.S., Jaffe A.J., Chang G., Shottenfeld R., Meyer R.E., and Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 881-887
37. Palfai T., Davidson D., and Swift R. Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies. Exp. Clin. Psychopharmacol. 7 (1999) 266-273
38. Pettinati H.M., O'Brien C.P., Rabinowitz A.R., Wortman S.P., Oslin D.W., Kampman K.M., et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J. Clin. Psychopharmacol. 26 (2006) 610-625
39. Pomerleau O.F., Fertig J., Baker L., and Cooney N. Reactivity to alcohol cues in alcoholics and non-alcoholics: implications for a stimulus control analysis of drinking. Addict. Behav. 8 (1983) 1-10
40. Rankin H., Hodgson R., and Stockwell T. Cue exposure and response prevention with alcoholics: a controlled trial. Behav. Res. Ther. 21 (1983) 435-446
41. Rohsenow D.J., Monti P.M., Hutchison K.E., Swift R.M., Colby S.M., and Kaplan G.B. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J. Abnorm. Psychol. 109 (2000) 738-742
42. Rohsenow D.J., Monti P.M., Rubonis A.V., Gulliver S.B., Colby S.M., Binkoff J.A., et al. Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes. Addiction 96 (2001) 1161-1174
43. Rohsenow D.J., Monti P.M., Rubonis A.V., Sirota A.D., Niaura R.S., Colby S.M., et al. Cue reactivity as a predictor of drinking among male alcoholics. J. Consult. Clin. Psychol. 62 (1994) 620-626
44. Sanger D.J., and McCarthy P.S. A comparison of the effects of opiate antagonists on operant and ingestive behavior. Pharmacol. Biochem. Behav. 16 (1982) 1013-1015
45. Schaefer G.J., and Michael R.P. Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats. Pharmacol. Biochem. Behav. 23 (1985) 797-802
46. Schindler C.W., Panlilio L.V., and Goldberg S.R. Second-order schedules of drug self-administration in animals. Psychopharmacology (Berl) 163 (2002) 327-344
47. Schindler C.W., Wu X.-Z., Su T.-P., Goldberg S.R., and Katz J.L. Enhanced sensitivity to behavioral effects of naltrexone in rats. J. Pharmacol. Exp. Ther. 252 (1990) 8-14
48. Sharpe A.L., and Samson H.H. Effect of naloxone on appetitive and consummatory phases of ethanol self-administration. Alcohol. Clin. Exp. Res. 25 (2001) 1006-1011
49. Sinclair J.D. New treatment options for substance abuse from a public health viewpoint. Ann. Med. 30 (1998) 406-411
50. Sinclair J.D. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol. Alcohol. 36 (2001) 2-10
51. Sitharthan T., Sitharthan G., Hough M.J., and Kavanagh D.J. Cue exposure in moderation drinking: a comparison with cognitive-behavior therapy. J. Consult. Clin. Psychol. 65 (1997) 878-882
52. Timar J., Gyarmati Z., and Furst Z. The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine. Brain. Res. Bull. 64 (2005) 417-424
53. Trujillo K.A., Belluzzi J.D., and Stein L. Naloxone suppression of self-stimulation is independent of response difficulty. Pharmacol Biochem. Behav. 33 (1989) 147-155
54. Trujillo K.A., Belluzzi J.D., and Stein L. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit. Brain Res. 492 (1989) 15-28
55. Turkkan J.S., McCaul M.E., and Stitzer M.L. Psychophysiological effects of alcohol-related stimuli: II. Enhancement with alcohol availability. Alcohol. Clin. Exp. Res. 13 (1989) 392-398
56. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880
57. Williams K.L. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding. Alcohol. Clin. Exp. Res. 31 (2007) 39-47